Therapeutic treatment of group A streptococcal infections
US5997862A · kind A · utility
37Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 1997 |
| Grant date | Dec 7, 1999 |
| Priority date | — |
| Expiry date | Oct 31, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01017
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an oral delivery system containing a group c streptococcal phage associated lysin enzyme for the prophylactic and therapeutic treatment of Streptococcal A throat infections, commonly known as strep throat.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.